These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10651962)

  • 61. Superimposed linear psoriasis: a historical case revisited.
    Happle R
    J Dtsch Dermatol Ges; 2011 Dec; 9(12):1027-8; discussion 1029. PubMed ID: 22026425
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ILVEN - COMPLETE REMISSION AFTER ADMINISTRATION OF TOPICAL CORTICOSTEROID (CASE REVIEW).
    Wollina U; Tchernev G
    Georgian Med News; 2017 Feb; (263):10-13. PubMed ID: 28452721
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immediacy is both a liability and an asset of the Internet.
    Huntley A
    Dermatol Online J; 1997 Dec; 3(2):11b. PubMed ID: 10217739
    [No Abstract]   [Full Text] [Related]  

  • 64. Psoriasis.
    McDonald CJ
    Minn Med; 1974 Oct; 57(10):813-20. PubMed ID: 4608273
    [No Abstract]   [Full Text] [Related]  

  • 65. Linear psoriasis.
    Chien P; Rosenman K; Cheung W; Wang N; Sanchez M
    Dermatol Online J; 2009 Aug; 15(8):4. PubMed ID: 19891912
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Skin Cap: what have we learned, and when did we learn it?
    Smith K
    Dermatol Online J; 1997 Dec; 3(2):11c. PubMed ID: 10217740
    [No Abstract]   [Full Text] [Related]  

  • 67. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
    Mommers JM; van Erp PE; van De Kerkhof PC
    Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis.
    Mazzotta A; Esposito M; Carboni I; Schipani C; Chimenti S
    J Dermatolog Treat; 2007; 18(2):84-7. PubMed ID: 17520464
    [TBL] [Abstract][Full Text] [Related]  

  • 69. VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis.
    Mommers JM; Van Rossum MM; Kooijmans-Otero ME; Parker GL; van de Kerkhof PC
    Br J Dermatol; 2000 Feb; 142(2):259-66. PubMed ID: 10730758
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment.
    Forman SB; Higginson R; Garrett AB
    J Drugs Dermatol; 2008 Oct; 7(10):972-3. PubMed ID: 19112763
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
    Mensing H; Korsukewitz G; Yawalkar S
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of nail psoriasis with topical application of clobetasol propionate 0.05% solution: a pilot study.
    Brandi N; Starace M; Alessandrini A; Bruni F; Piraccini BM
    Eur J Dermatol; 2018 Feb; 28(1):111-112. PubMed ID: 29336322
    [No Abstract]   [Full Text] [Related]  

  • 73. Manifestation of psoriasis in the oral cavity.
    Fatahzadeh M
    Quintessence Int; 2016 Mar; 47(3):241-7. PubMed ID: 26665263
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma cell vulvitis and response to topical steroids: a case report.
    David L; Massey K
    Int J STD AIDS; 2003 Aug; 14(8):568-9. PubMed ID: 12935388
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disseminated Warty Papules and Plaques: Answer.
    Kailas A; Heilman E; Kazlouskaya V
    Am J Dermatopathol; 2019 Mar; 41(3):232-233. PubMed ID: 30801342
    [No Abstract]   [Full Text] [Related]  

  • 76. Keeping psoriasis under wraps.
    Griffiths CE
    J Dermatolog Treat; 2001 Sep; 12(3):133. PubMed ID: 12243702
    [No Abstract]   [Full Text] [Related]  

  • 77. Guidelines for using superpotent topical steroids.
    Prawer SE; Katz HI
    Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A case of verrucous psoriasis.
    Monroe HR; Hillman JD; Chiu MW
    Dermatol Online J; 2011 May; 17(5):10. PubMed ID: 21635832
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Topical clobetasol propionate compared with placebo in the treatment of unretractable foreskin.
    Lindhagen T
    Eur J Surg; 1996 Dec; 162(12):969-72. PubMed ID: 9001879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.